Cargando…
Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis
BACKGROUND: Systemic immune-inflammation index (SII) has been suggested to be effective to reflect the inflammatory status and thus may be an underlying biomarker for prognosis prediction. This hypothesis has been demonstrated in meta-analyses on several cancer types. However, there was no study to...
Autores principales: | Ji, Yongfang, Wang, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414550/ https://www.ncbi.nlm.nih.gov/pubmed/32767977 http://dx.doi.org/10.1186/s12957-020-01974-w |
Ejemplares similares
-
Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis
por: Zhang, Yantao, et al.
Publicado: (2020) -
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
por: Yang, Ruonan, et al.
Publicado: (2018) -
Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
por: Liu, Jingxin, et al.
Publicado: (2019) -
Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis
por: Huang, Yilong, et al.
Publicado: (2020) -
Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis
por: Dong, Meilian, et al.
Publicado: (2020)